137 related articles for article (PubMed ID: 17507814)
21. Two-dimensional spectroscopic imaging for pretreatment evaluation of prostate cancer: comparison with the step-section histology after radical prostatectomy.
Weis J; Ahlström H; Hlavcak P; Häggman M; Ortiz-Nieto F; Bergman A
Magn Reson Imaging; 2009 Jan; 27(1):87-93. PubMed ID: 18599244
[TBL] [Abstract][Full Text] [Related]
22. Histopathological characteristics of lymph node metastases predict cancer-specific survival in node-positive prostate cancer.
Boormans JL; Wildhagen MF; Bangma CH; Verhagen PC; van Leenders GJ
BJU Int; 2008 Dec; 102(11):1589-93. PubMed ID: 18710447
[TBL] [Abstract][Full Text] [Related]
23. Proton spectroscopic and dynamic contrast-enhanced magnetic resonance: a modern approach in prostate cancer imaging.
Sciarra A; Salciccia S; Panebianco V
Eur Urol; 2008 Sep; 54(3):485-8. PubMed ID: 18439748
[No Abstract] [Full Text] [Related]
24. [Value of 3D 1H-MRS with body coil at 3T in the differential diagnosis of the prostate cancer].
Wang F; Dai YP; Sun XZ; Guo Y; Chen YQ; Mao LJ; Wang DH; Deng CH
Zhonghua Nan Ke Xue; 2009 May; 15(5):431-6. PubMed ID: 19514556
[TBL] [Abstract][Full Text] [Related]
25. Tumor volume and metabolism of prostate cancer determined by proton magnetic resonance spectroscopic imaging at 3T without endorectal coil reveal potential clinical implications in the context of radiation oncology.
Créhange G; Parfait S; Liegard M; Maingon P; Ben Salem D; Cochet A; Funes de la Vega M; Cormier L; Bonnetain F; Mirjolet C; Brunotte F; Walker PM
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1087-94. PubMed ID: 20615624
[TBL] [Abstract][Full Text] [Related]
26. Lymph node assessment and lymphadenectomy in prostate cancer.
Ordon M; Nam RK
J Surg Oncol; 2009 Mar; 99(4):215-24. PubMed ID: 19170044
[TBL] [Abstract][Full Text] [Related]
27. Prediction of locally recurrent prostate cancer after radiation therapy: incremental value of 3T diffusion-weighted MRI.
Kim CK; Park BK; Lee HM
J Magn Reson Imaging; 2009 Feb; 29(2):391-7. PubMed ID: 19161194
[TBL] [Abstract][Full Text] [Related]
28. Editorial comment on: role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer.
Hara N
Eur Urol; 2008 Sep; 54(3):598-9. PubMed ID: 18226440
[No Abstract] [Full Text] [Related]
29. Editorial comment on: role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer.
Fütterer JJ; Barentsz JO
Eur Urol; 2008 Sep; 54(3):599-600. PubMed ID: 18226439
[No Abstract] [Full Text] [Related]
30. Multiparametric magnetic resonance imaging of the prostate: current status in prostate cancer detection, localization, and staging.
Macura KJ
Semin Roentgenol; 2008 Oct; 43(4):303-13. PubMed ID: 18774034
[No Abstract] [Full Text] [Related]
31. Magnetic resonance spectroscopy detects cancer in draining lymph nodes.
Mountford CE; Lean CL; Hancock R; Dowd S; Mackinnon WB; Tattersall MH; Russell P
Invasion Metastasis; 1993; 13(2):57-71. PubMed ID: 8225853
[TBL] [Abstract][Full Text] [Related]
32. MR imaging in local staging of prostate cancer.
Fütterer JJ
Eur J Radiol; 2007 Sep; 63(3):328-34. PubMed ID: 17689908
[TBL] [Abstract][Full Text] [Related]
33. Longitudinally monitoring chemotherapy effect of malignant musculoskeletal tumors with in vivo proton magnetic resonance spectroscopy: an initial experience.
Hsieh TJ; Li CW; Chuang HY; Liu GC; Wang CK
J Comput Assist Tomogr; 2008; 32(6):987-94. PubMed ID: 19204465
[TBL] [Abstract][Full Text] [Related]
34. Newer imaging modalities to assist with target localization in the radiation treatment of prostate cancer and possible lymph node metastases.
John SS; Zietman AL; Shipley WU; Harisinghani MG
Int J Radiat Oncol Biol Phys; 2008; 71(1 Suppl):S43-7. PubMed ID: 18406936
[TBL] [Abstract][Full Text] [Related]
35. Radioisotope guided sentinel lymph node dissection in patients with localized prostate cancer: results of the first 100 cases.
Bastide C; Brenot-Rossi I; Garcia S; Rossi D
Eur J Surg Oncol; 2009 Jul; 35(7):751-6. PubMed ID: 18538526
[TBL] [Abstract][Full Text] [Related]
36. Thirty-two-channel coil 3T magnetic resonance-guided biopsies of prostate tumor suspicious regions identified on multimodality 3T magnetic resonance imaging: technique and feasibility.
Hambrock T; Fütterer JJ; Huisman HJ; Hulsbergen-vandeKaa C; van Basten JP; van Oort I; Witjes JA; Barentsz JO
Invest Radiol; 2008 Oct; 43(10):686-94. PubMed ID: 18791410
[TBL] [Abstract][Full Text] [Related]
37. Prostate cancer detection: magnetic resonance (MR) spectroscopic imaging.
Vilanova JC; Barceló J
Abdom Imaging; 2007; 32(2):253-61. PubMed ID: 17476554
[TBL] [Abstract][Full Text] [Related]
38. [MR imaging and MR spectroscopy in prostate cancer].
Sugimura K
Nihon Rinsho; 2005 Feb; 63(2):247-52. PubMed ID: 15714974
[TBL] [Abstract][Full Text] [Related]
39. Prostate cancer. Staging through laparoscopic lymphadenectomy.
Newton M; Moore S; Gaehle KE
AORN J; 1994 Apr; 59(4):823-33, 836; quiz 837-40. PubMed ID: 8210240
[No Abstract] [Full Text] [Related]
40. Magnetic resonance spectroscopic imaging: current status in the management of prostate cancer.
Nayyar R; Kumar R; Kumar V; Jagannathan NR; Gupta NP; Hemal AK
BJU Int; 2009 Jun; 103(12):1614-20. PubMed ID: 19338548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
